Fine tuning the management of axial spondyloarthritis

被引：0

作者：

Daniel Wendling

Clément Prati

机构：

[1] University Teaching Hospital,Daniel Wendling is at the Department of Rheumatology

[2] CHRU de Besançon,Clément Prati is at the Department of Rheumatology

[3] Boulevard Alexandre Fleming,undefined

[4] 25030 Besançon,undefined

[5] France; and at EA4266,undefined

[6] Université Bourgogne-Franche-Comté,undefined

[7] 32 Avenue de l'Observatoire,undefined

[8] 25030 Besançon,undefined

[9] France.,undefined

[10] and at EA4266,undefined

[11] Université Bourgogne-Franche-Comté,undefined

[12] 32 Avenue de l'Observatoire,undefined

[13] 25030 Besançon,undefined

[14] France.,undefined

[15] University Teaching Hospital,undefined

[16] CHRU de Besançon,undefined

[17] Boulevard Alexandre Fleming,undefined

[18] 25030 Besançon,undefined

[19] France; and at EA4267,undefined

[20] Fédération Hospitalo-Universitaire Integrates Centre for Research in Inflammatory Diseases (FHU INCREASE),undefined

[21] Université Bourgogne-Franche-Comté,undefined

[22] 25030 Besançon,undefined

[23] France.,undefined

[24] and at EA4267,undefined

[25] Fédération Hospitalo-Universitaire Integrates Centre for Research in Inflammatory Diseases (FHU INCREASE),undefined

[26] Université Bourgogne-Franche-Comté,undefined

[27] 25030 Besançon,undefined

[28] France.,undefined

来源：

Nature Reviews Rheumatology | 2017年 / 13卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Updated recommendations for the management of axial spondyloarthritis provide a useful framework for physicians treating this disease. However, the guidance on use of biologic therapies and treat-to-target strategies seems to raise more questions than it answers.

引用

页码：199 / 200

页数：1

共 11 条

[1]

Taurog JD(2016)Ankylosing spondylitis and axial spondyloarthritis N. Engl. J. Med. 374 2563-2574

[2]

Chhabra A(2009)The development of Assessment of Spondyloarthritis International Society classification criteria for axial spondyloarthritis (part II): validation and final selection Ann. Rheum. Dis. 68 777-783

[3]

Colbert RA(2014)Recommendations of the French Society for Rheumatology (SFR) on the everyday management of patients with spondyloarthritis Joint Bone Spine 81 6-14

[4]

Rudwaleit M(2014)Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force Ann. Rheum. Dis. 73 6-16

[5]

Wendling D(2016)An overview of investigational new drugs for treating ankylosing spondylitis Expert Opin. Investig. Drugs 25 95-104

[6]

Smolen JS(2016)TNFα antagonist therapy in axial spondyloarthritis: can we do better? Joint Bone Spine 83 247-249

[7]

Wendling D(2014)Should non-steroidal anti-inflammatory drugs be used continuously in ankylosing spondylitis? Joint Bone Spine 81 308-312

[8]

Prati C(2016)Fibromyalgia in spondyloarthritis: effect on disease activity assessment in clinical practice J. Rheumatol. 43 2056-2063

[9]

Guellec D(2013)Efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis: results of a randomized placebo-controlled trial (ABILITY-1) Ann. Rheum. Dis. 72 815-822

[10]

Wach J(undefined)undefined undefined undefined undefined-undefined

← 1 2 →